Coaptite Injectable Implant
PMA P040047
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP040047 | Date10 Nov 2005 | StatusActive |
Official records
- FDA PMA database P040047
From the FDA record
FDA PMA P040047
- Received by the FDA
- 9 Dec 2004
- FDA decision
- 10 Nov 2005
- FDA review time
- 336 days from receipt to decision
- Docket number
- 05M-0477
APPROVAL FOR COAPTITE. THE DEVICE IS INDICATED FOR SOFT TISSUE AUGMENTATION IN THE TREATMENT OF STRESS URINARY INCONTINENCE (SUI) DUE TO INTRINSIC SPHINCTER DEFICIENCY (ISD) IN ADULT FEMALES.
Recalls
-
- Ongoing Z-0401-2021
The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.
Timeline
- Approved FDA PMA P040047
- Recall initiated FDA recalls Z-0401-2021
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- Coaptite
- Generic name
- AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
- PMA number
- FDA product code
- LNM
- Device class
- Class III
- Advisory committee
- Gastroenterology, Urology
- FDA decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
The Coaptite Injectable Implant is a bulking agent classified as an Agent, Bulking, Injectable for Gastro-Urology Use, designed for soft tissue augmentation. It is intended to treat stress urinary incontinence (SUI) caused by intrinsic sphincter deficiency (ISD) in adult females by reinforcing the urethral support mechanism.
This device is supplied as a sterile, injectable implant and is regulated under FDA Premarket Approval (PMA P040047). Administered via urological procedures, it is intended for single-use per patient application. No MRI safety data or reusable configurations are specified, and storage conditions align with standard sterile injectable protocols.
Devices cleared under P040047
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Coaptite 8005P10 | M0068903000 / 8005P10 | 08714729804796 | Total Volume 1 mL | On the market |
Similar devices
Other devices filed under FDA product code LNM (Agent, Bulking, Injectable For Gastro-Urology Use).
- Bulkamid Urethral Bulking System by Boston Scientific
- Durasphere Injectable Bulking Agent by Carbon Medical Technologies, Inc.
- Enteryx Procedure Kit by Boston Scientific
- Macroplastique Implants MPQ-2.5 by Uroplasty, LLC
- Bard URYX Urethral Bulking Agent by C. R. Bard, Inc.
- Macroplastique Implants by Uroplasty, LLC
- Solesta Injectable Gel by Palette Life Sciences Inc.
- Contigen Bard Collagen Implant by Allergan
- Deflux Injectable Gel by Palette Life Sciences Inc.